PPAR-gamma activation has been shown to increase myocardial expression of glucose transporters, promote carbohydrate substrate utilization in cardiac myocytes and intact hearts [17,18], and attenuate pro-inflammatory cytokine expression in activated cardiomyocytes [19], experimental myocarditis [20] or chronic LV failure due to myocardial infarction [21]. Here, PPARG is linked to myocardial infarction.